What is Acadia Pharmaceuticals's income tax?

Acadia Pharmaceuticals (ACAD) reported income tax of $344K in Q1 2026.

How has Acadia Pharmaceuticals's income tax changed year-over-year?

Acadia Pharmaceuticals's income tax decreased by 96.1% year-over-year, from $8.79M to $344K.

What is the long-term trend for Acadia Pharmaceuticals's income tax?

Over 3 years (2021 to 2025), Acadia Pharmaceuticals's income tax has grown at a 795.5% compound annual growth rate (CAGR), from $351K to -$252.1M.

What does income tax mean?

Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.

Acadia Pharmaceuticals ACAD Income Tax

Income Tax at other companies

BiogenBIIB

$58.2M-17.7%

Neurocrine BiosciencesNBIX

$48.9M+619%

Catalyst PharmaceuticalCPRX

$20.5M+40.9%

PTC TherapeuticsPTCT

$347K-99.5%

TG TherapeuticsTGTX

$586K+43.6%

Arrowhead ResearchARWR

$7K-99.6%

Segments

By segment

See full

Reportable Segment Aggregation Before Other Operating$344K-96.1%

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.7B+37.0%

Enterprise value$3.47B+36.6%

P/E9.9×-2.0×

P/S3.4×+0.7×

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Reported directly by Acadia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's income tax?: Acadia Pharmaceuticals (ACAD) reported income tax of $344K in Q1 2026.
How has Acadia Pharmaceuticals's income tax changed year-over-year?: Acadia Pharmaceuticals's income tax decreased by 96.1% year-over-year, from $8.79M to $344K.
What is the long-term trend for Acadia Pharmaceuticals's income tax?: Over 3 years (2021 to 2025), Acadia Pharmaceuticals's income tax has grown at a 795.5% compound annual growth rate (CAGR), from $351K to -$252.1M.
What does income tax mean?: Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.